Evidence map›Paper›PMID 28522551›Full record

ArticleBioscience reports2017

Inhibition of

Xianzhu Zeng, Na Liu, Jing Zhang, Lei Wang, Zhecheng Zhang, Ju Zhu, Qian Li, Yuwen Wang

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.Neurology(R) neuroimmunology & neuroinflammation · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xianzhu ZengDepartment of Neurology, Third Central Hospital of Tianjin, Tianjin 300170, China.
Na LiuDepartment of Neurology, The Third Central Clinical College of Tianjin Medical University, Tianjin 300170, China.
Jing ZhangDepartment of Neurology, Third Central Hospital of Tianjin, Tianjin 300170, China.
Lei WangDepartment of Neurology, Third Central Hospital of Tianjin, Tianjin 300170, China.
Zhecheng ZhangDepartment of Neurology, Third Central Hospital of Tianjin, Tianjin 300170, China zhechengzhangtjtch@hotmail.com.
Ju ZhuDepartment of Neurology, Third Central Hospital of Tianjin, Tianjin 300170, China.
Qian LiDepartment of Neurology, Third Central Hospital of Tianjin, Tianjin 300170, China.
Yuwen WangDepartment of Neurology, Third Central Hospital of Tianjin, Tianjin 300170, China.
Tianjin Third Central Hospital · CNTianjin Fire Research Institute · CNTianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemic stroke, a major cause of death, is caused by occlusion of a blood vessel, resulting in significant reduction in regional cerebral blood flow. MiRNAs are a family of short noncoding RNAs (18-22 nts) and bind the 3'-UTR of their target genes to suppress the gene expression post-transcriptionally. In the present study, we report that

Indexed as

Gene Expression Regulation, EnzymologicAnimalsAstrocytesBrain IschemiaHexokinaseMaleMicroRNAsNeuronsRatsRats, WistarHexokinaseMicroRNAsMIRN143 microRNA, ratHexokinase 2ischemia cerebral injurymiR-143

Identifiers

PMID28522551
PMCPMC6434090
OpenAlexW2614573579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.